Try Alerts Free   |   Login
Health Care › Services-Medical Laboratories

ENZ Price Correlated With Financials For Enzo Biochem

Free historical financial statements for Enzo Biochem Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 45 quarters since 2011. Compare with ENZ stock chart to see long term trends.

ENZ Stock Compared to Quarterly

ENZ Income Statement

Revenue, Net:18276000
Revenue Per Share:0.3751
Cost of Goods & Services Sold:14671000
Selling, General & Admin Expense:11451000
Research & Development Expense:996000
Total Operating Expenses:9000
Operating Income:-9913000
Income Taxes:0
Net Income:-10635000
Earnings Per Share, Basic:106000
Shares Outstanding, Basic Avg:48720454

ENZ Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:780000
Change in Accounts Receiveable:11000
Net Cash from Operations:-8693000
Net Cash from Operations Per Share:-0.1784
Net Cash from Financing Activities:-95000
Property, Plant & Equipment Purchases:null
Net Cash from Investing Activities:-652000
Net Change in Cash & Equivalents:-9468000

ENZ Balance Sheet

Cash and Cash Equivalents:13135000
Short-Term Investments:null
Accounts Receivable, Net:11515000
Inventories:15787000
Total Current Assets:44579000
Property, Plant & Equipment, Net:17140000
Total Assets:85199000
Current Portion of Long-Term Debt:228000
Total Short-Term Liabilities:24253000
Long Term Debt, Non-Current Portion:3986000
Total Liabilities:40209000

Insider Trading

 
Change
Value
Transaction
SEC Form 4
Wolf James G.   10% Owner
280,000 sh at $3
$700,000
Buy
Erfanian Hamid   Chief Executive Officer
100,000 sh at $2
$197,000
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Harbert Fund Advisors, Inc.
5,175,913 sh
 
$11,542
Renaissance Technologies LLC
2,909,664 sh
-101,500 sh
-3%
$6,489
-$2,243
Roumell Asset Management, LLC
2,390,211 sh
-2,431 sh
0%
$5,330
-$1,609
Vanguard Group Inc
1,770,749 sh
 
$3,949
Dimensional Fund Advisors LP
1,593,865 sh
-8,510 sh
-1%
$3,554
$237
Blackrock Inc.
1,468,121 sh
-62,134 sh
-4%
$3,275
$108
Viex Capital Advisors, LLC
1,334,479 sh
-202,378 sh
-13%
$2,976
-$205
Fuller & Thaler Asset Management, Inc.
971,010 sh
13,525 sh
1%
$2,165
$183
Potomac Capital Management, Inc.
559,500 sh
 
$1,248
Morgan Stanley
389,198 sh
-31,558 sh
-8%
$867
-$4
Geode Capital Management, LLC
357,544 sh
977 sh
0%
$797
$59
Bridgeway Capital Management Inc
320,700 sh
-55,000 sh
-15%
$715
-$63
Rbf Capital, LLC
250,359 sh
 
$559
State Street Corp
185,639 sh
 
$414
Northern Trust Corp
104,068 sh
-7,465 sh
-7%
$232
-$91
Bank Of New York Mellon Corp
87,281 sh
1,998 sh
2%
$194
$18
Corsair Capital Management, L.P.
75,049 sh
23 sh
0%
$167
$12
Sns Financial Group, LLC
62,500 sh
 
$139
Susquehanna International Group, Llp
Put options for 52,600 sh
52,600 sh
NEW
$117
$117
Group One Trading, L.P.
51,594 sh
51,594 sh
NEW
$115
$115

Data imported from Enzo Biochem Inc SEC filings. Check original filings before making any investment decision.